Case Study: Ferring Pharmaceuticals achieves a global, scalable bioprocess data platform with Genedata Bioprocess

Ferring Pharmaceuticals - Customer Case Study

Ferring Pharmaceuticals needed a state-of-the-art, scalable data infrastructure to unify biologics development across CLD, USP, DSP and analytics groups at multiple international R&D sites, eliminate manual handovers and data silos, and support diverse modalities from mAbs to gene and microbiome therapies. Ferring selected Genedata and its Genedata Bioprocess platform to meet requirements for structured data capture, instrument integration, ELN interoperability and full traceability.

Genedata deployed Genedata Bioprocess across the new FBIC site and other international locations, completing initial setup and user training within three months and integrating instruments and NGS workflows via off‑the‑shelf connectors and APIs. The platform created a single, auditable data source, reduced manual data collation, and delivered measurable efficiency gains (e.g., <10 seconds to query stock, <1 minute to find a certificate, <3 minutes to compare multiple batch data series), improved data quality and compliance, and enabled faster, more scalable development of novel therapeutics.

Ferring Pharmaceuticals

Björn Hock

VP Biologics Technologies and Development